Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations
June 30, 2026 - 12:00 PM – 2:00 PM
CertaraJune 10, 2026
Model Smarter, Not Harder: Introducing Model Designer
Watch Model Designer on demand: Certara's browser based tool for faster NLME model discovery, configuration,…
CertaraJune 10, 2026
Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study
Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…
CertaraJune 9, 2026
Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies
Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.
CertaraJune 9, 2026
Beyond compliance: What ICH M15 means for the future of drug development
Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…
CertaraJune 9, 2026
How interactive value communication tools strengthen the value proposition in healthcare
Learn how interactive value communication tools help demonstrate healthcare value, support payer discussions, and strengthen…
CertaraJune 9, 2026
The Case for Simulating Pregnancy
Pregnant women are routinely excluded from drug trials, leaving clinicians without dosing guidance. Discover how…
CertaraJune 9, 2026
The end of the national launch: Why regional pharma market access now determines commercial success
Regional pharma market access is reshaping uptake. Build a regional market access strategy to navigate…
CertaraJune 5, 2026
Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients
See how a QSP model guided efficacy-proximal FIH dosing for ISB 2001 in the TRIgnite-1…
CertaraJune 4, 2026
Applying AI-Driven Biosimulation to Drug Discovery
Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…
CertaraJune 2, 2026
